What is the innovation for, if a million people die for want of vaccine. Governments can pool to give 5 billion dollar incentive to make the vaccine recipe freeware. Patent law specifics are outdated though the law is good in theory and practice. And anti monopoly or fair competition viewpoint also need to be considered. Having a monopoly over production while at the same time being absolved of adverse consequences/ reactions of vaccines means laws and their applications can be tweaked in pressing times. And what about the human volunteer participants who underwent the efficacy trials, do they receive a share of profits?
IP rights of Covaxin are already with an Indian company. Indian governments challenge is helping them scale up production, not advocating for free handouts from other countries
This Robinhood thinking looks good in media and bureaucracy but real world innovation doesn’t happen like this. There is a reason why innovation happens in countries like US, Japan, Germany, France and not in countries like India – because we don’t value innovators, inventors, engineers and entrepreneurs. We only value sarkaari naukri and give too much importance to media.
No patents shouldn’t be revoked, because I want innovation to continue.
IP should not be waived. Companies did research and they must be rewarded for their research and development. The Print needs to get out of that third world mindset. I can see patterns, why India is still a poor third world country.
This article should be published in an American portal so that they can read it.
What is the innovation for, if a million people die for want of vaccine. Governments can pool to give 5 billion dollar incentive to make the vaccine recipe freeware. Patent law specifics are outdated though the law is good in theory and practice. And anti monopoly or fair competition viewpoint also need to be considered. Having a monopoly over production while at the same time being absolved of adverse consequences/ reactions of vaccines means laws and their applications can be tweaked in pressing times. And what about the human volunteer participants who underwent the efficacy trials, do they receive a share of profits?
IP rights of Covaxin are already with an Indian company. Indian governments challenge is helping them scale up production, not advocating for free handouts from other countries
This Robinhood thinking looks good in media and bureaucracy but real world innovation doesn’t happen like this. There is a reason why innovation happens in countries like US, Japan, Germany, France and not in countries like India – because we don’t value innovators, inventors, engineers and entrepreneurs. We only value sarkaari naukri and give too much importance to media.
No patents shouldn’t be revoked, because I want innovation to continue.
IP should not be waived. Companies did research and they must be rewarded for their research and development. The Print needs to get out of that third world mindset. I can see patterns, why India is still a poor third world country.